Granting Stock Options to Directors
First written in FY2024-Q2. 5 of 8 entries say "Advanced", first in FY2025-H1. Latest entry: FY2027-H1.
106 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「Resolution date 30 June 2026 Category and number of eligible persons (people) Directors of the Company 4 Number of stock acquisition rights (rights) * 333 (Note 1) Class, description and number of shares underlying the stock acquisition rights (shares) * Common shares 66,600 (Note 1) Exercise period for the stock acquisition rights * From 23 July 2026 To 22 July 2056」
Based on the resolution dated 30 June 2026, the Company issued 333 stock acquisition rights to 4 directors, covering 66,600 underlying shares, with an exercise period from 23 July 2026 to 22 July 2056. - FY2026AdvancedAnnual report
「Other (exercise of stock acquisition rights) 91,200 90」
During the fiscal year, the company disposed of 91,200 treasury shares through the exercise of stock acquisition rights, reducing treasury shares from 421,400 to 330,200. - FY2026-H1AdvancedAnnual report
「Resolution date 30 June 2025 Eligible recipients and number Directors of the company 4 Number of stock acquisition rights* 333 (Note 1) Class, terms and number of shares underlying the stock acquisition rights* Common shares 66,600 (Note 1) Exercise period* From 24 July 2025 To 23 July 2055」
Based on the resolution of 30 June 2025, the company issued 333 stock acquisition rights to 4 directors, covering 66,600 shares, and set the exercise period from 24 July 2025 to 23 July 2055. - FY2025-H1AdvancedAnnual report
「Resolution date: 28 June 2024; eligible recipients and number: directors of the company, 5; number of stock acquisition rights: 408* (Note 1); class, terms and number of shares underlying the stock acquisition rights: common shares, 81,600* (Note 1); exercise period*: 24 July 2024 to 23 July 2054.」
Based on the resolution of 28 June 2024, the company newly issued 408 stock acquisition rights to 5 directors, covering 81,600 shares, with an exercise period from 24 July 2024 to 23 July 2054. - FY2024RestatedAnnual report
「Ninth Series of Stock Acquisition Rights; resolution date: 30 June 2023; eligible recipients and number: directors of the company, 5; number of stock acquisition rights: 501*; class, terms and number of shares underlying the stock acquisition rights: common shares, 100,200*.」
The company has restated the outstanding terms at the end of the fiscal year and the number of underlying shares for the Ninth Series of Stock Acquisition Rights granted to 5 directors. - FY2024-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: resolution date: 30 June 2023; eligible recipients and number: directors of the company, 5; number of stock acquisition rights: 501; class, terms and number of shares underlying the stock acquisition rights: common shares, 100,200; exercise period: 26 July 2023 to 25 July 2053.」
Based on the resolution of 30 June 2023, the company issued 501 stock acquisition rights to 5 directors, covering 100,200 shares. The exercise period runs from 26 July 2023 to 25 July 2053.